So which weight loss injection works best
The growth of GLP-1 treatment within diabetes Glucagon-like peptide 1 (GLP-1) receptor agonists have taken the healthcare world by storm, becoming one of the most successful drug classes of all time, reaching an astonishing $110 billion in sales in 2024 alone 1
Read Clinical Innovation Director Leon van Wouwe new think piece on unlocking the future of type 1 diabetes care through early diagnosis: #Type1Diabetes #EarlyDiagnosis #AIinHealthcare #PrecisionMedicine #VolvGlobal #ClinicalInnovation #PatientCentricity #leonvanwouwe #wheretechnologymeetshuman #everyindividualmatters To view or add a comment, sign in Optimising Type 2 Diabetes Management: Oral Semaglutide vs Linagliptin Selecting the right therapy involves balancing efficacy, safety, and patient convenience
GLP-1 also reduces appetite, while GIP may have a role in fat deposition and potentially mitigating some of the nausea associated with GLP-1 receptor agonists
The complete peptide storage guide covers these considerations in more detail
Looks like both generic and reference product are same